By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Serono Pharmaceutical Research Institute (SPRI) 

14, Chemin des Aulx

Plan-les-Ouates    1228  Geneva
Phone: 41-22-706-96-66 Fax: 41-22-794-69-65


Company News
Aureus Pharma Licenses AurSCOPE(R) GPCR To Serono Pharmaceutical Research Institute (SRA) 4/11/2006 11:58:35 AM
Former Executives For Serono, Inc. (SRA) Charged With Conspiracy And Offering Kickbacks To Doctors10/19/2005 5:12:42 PM
Serono, Inc. (SRA) Announces FDA Approval Of Rebif(R) Titration Pack10/19/2005 5:12:30 PM
Serono, Inc. (SRA) And IVAX Corporation (IVX) To Initiate Phase III Clinical Trial Of Mylinax(R) In Multiple Sclerosis10/19/2005 5:12:07 PM
The Medical House PLC (MLH.L) Needle-Free Injection Of Human Growth Hormone: Licence Agreement With Serono, Inc. (SRA)10/19/2005 5:12:07 PM
Serono, Inc. (SRA) Announces The Availability Of Saizen(r) For Adult Growth Hormone Deficiency (AGHD) In The United States10/19/2005 5:12:04 PM
FDA Approves Serono's (SRA) Luveris(R) For Concomitant Use With Gonal-f(R)10/19/2005 5:11:50 PM
Dr. Peggy Pence Joins CytoDyn's Board10/19/2005 5:11:28 PM
ProMetic Life Sciences Inc. (CC:PLI) And Serono International S.A. (SRA) Sign A Development Aand Collaboration Agreement10/19/2005 5:10:24 PM